4. Malhotra P, Gella V, Guru Murthy GS, Varma N, Varma S. 2016; High incidence of aplastic anemia is linked with lower socioeconomic status of Indian population. J Public Health (Oxf). 38:223–8. DOI:
10.1093/pubmed/fdv027. PMID:
25755247.
Article
5. Shallis RM, Ahmad R, Zeidan AM. 2018; Aplastic anemia: etiology, molecular pathogenesis, and emerging concepts. Eur J Haematol. 101:711–20. DOI:
10.1111/ejh.13153. PMID:
30055055.
Article
8. Luzzatto L, Risitano AM. 2018; Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol. 182:758–76. DOI:
10.1111/bjh.15443. PMID:
29974931.
Article
9. Kastrinaki MC, Pavlaki K, Batsali AK, et al. 2013; Mesenchymal stem cells in immune-mediated bone marrow failure syndromes. Clin Dev Immunol. 2013:265608. DOI:
10.1155/2013/265608. PMID:
24386000. PMCID:
PMC3872391.
Article
12. Araujo Z, Palacios A, Biomon R, et al. 2017; Concordance between IFNγ gene +874 A/T polymorphism and interferon-γ expression in a TB-endemic indigenous setting. Rev Soc Bras Med Trop. 50:199–207. DOI:
10.1590/0037-8682-0398-2016. PMID:
28562756.
Article
14. Yadav DK, Tripathi AK, Gupta D, et al. 2017; Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia. Blood Res. 52:264–9. DOI:
10.5045/br.2017.52.4.264. PMID:
29333402. PMCID:
PMC5762736.
16. Zheng M, Liu C, Fu R, et al. 2015; Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia. Int J Clin Exp Pathol. 8:3659–69. PMID:
26097547. PMCID:
PMC4466934.
17. Yu Z, Huang Z, Dai X, Wu X, Huang J. 2014; Th1/Th2 imbalance in the pathogenesis of chronic aplastic anemia. J Hard Tissue Biol. 23:455–60. DOI:
10.2485/jhtb.23.455.
Article
18. Găman A, Găman G, Bold A. 2009; Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors. Rom J Morphol Embryol. 50:669–74. PMID:
19942964.
19. Mavroudi I, Papadaki HA. 2012; Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia. Clin Dev Immunol. 2012:123789. DOI:
10.1155/2012/123789. PMID:
22956967. PMCID:
PMC3432560.
Article
20. Zhang JY, Chang H, Meng WT. 2008; The polymorphism of interferon gamma gene CA short tandem repeat is associated with aplastic anemia. Sichuan Da Xue Xue Bao Yi Xue Ban. 39:23–5. PMID:
18390192.
21. Deng S, Lin S, Shen J, Zeng Y. 2020; The relationship between interferon gamma (IFN-γ) single nucleotide polymorphism +874(T/A) and occurrence risk of aplastic anemia: a meta-analysis. Hematology. 25:85–90. DOI:
10.1080/16078454.2019.1631508. PMID:
32063160.
22. Zayed RA, Abdel-Hamid SM, El-Lithy H. 2016; The association of cytokine genes polymorphisms and susceptibility to aplastic anemia in Egyptian patients. Hematology. 21:106–12. DOI:
10.1179/1607845415Y.0000000038. PMID:
26214243.
Article
23. Bestach Y, Sieza Y, Attie M, et al. 2015; Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population. Leuk Lymphoma. 56:1793–8. DOI:
10.3109/10428194.2014.966707. PMID:
25248876.
24. Chang H, Zeng F, Zhang JY, et al. 2010; Association of the interferon-gamma single nucleotide polymorphism +874(T/A) with response to immunosuppressive therapy in patients with severe aplastic anemia. Blood Cells Mol Dis. 45:313–6. DOI:
10.1016/j.bcmd.2010.09.003. PMID:
20934357.
Article